Delribu Health (DHB), Launches "Kids Sleep Gummies" in the United States……Enters Children's Health Market

Vancouver-based Delivra Health Brands (DHB) is entering the children’s sleep aid product market, accelerating the expansion of its health and wellness product portfolio. The company announced that it will launch a new product, “Dream Water Kids Sleep Gummies,” under its core brand “Dream Water” in the U.S. market. The product is expected to be widely available through distributors, retail channels, and e-commerce platforms starting June 2026.

The newly announced Dream Water Kids Sleep Gummies are designed to promote gentle sleep in children. They feature a blend of chamomile and lemon balm, with 1 milligram of melatonin. The product also uses honey and cane sugar to add a mild sweetness, emphasizing safety and ingredient transparency. It is free from artificial colors, flavors, gelatin, and gluten.

Delivra Health CEO Gold Davy stated, “This product launch is an extension of our ongoing strategy to introduce high-quality innovative products that meet consumer wellness needs. It is especially meaningful for families concerned about their children’s sleep issues, providing a trusted option.” He added, “Positive feedback from multiple tests has confirmed the product’s potential, so we are bringing it to market earlier than originally planned.”

In addition to Dream Water, Delivra Health is expanding its product line focused on addressing common health issues such as chronic pain, anxiety, and sleep disorders through its LivRelief brand. The company emphasizes that millions of consumers have experienced improved quality of life through its products.

On the same day, based on a board resolution, the company also granted a total of 815,000 incentive stock options. The options have an exercise price of $0.16 per share, are valid for five years from the grant date, and vest in three equal parts each year. These stock options will be granted to directors, executives, employees, and some advisors, in accordance with Toronto Stock Exchange Venture Tier regulations and relevant securities laws.

Industry observers are paying close attention to whether this new product launch can strengthen Delivra Health’s position in the rapidly growing children’s sleep food market. It is believed that a strategy focusing on natural ingredients and low-stimulation formulas will be key to gaining consumer trust.

However, the company notes that the forward-looking statements regarding future plans and product performance included in this announcement are subject to risks and uncertainties. Actual results may differ due to macroeconomic changes, shifts in consumer trends, regulatory risks, and other factors. Some analysts suggest that, beyond the product launch itself, market response and channel expansion speed are more likely to significantly impact future performance.